|
|
|
|
|
|
Found 826 studies with search of: | Mexico |
Hide studies that are not seeking new volunteers.
|
|
1 | Enrolling by invitation | A Open Label Study of a Flexible Dose of Brivaracetam in Subjects 16 Years or Older Suffering From Epilepsy | ||||
Condition: | Epilepsy | |||||
Intervention: | Drug: Brivaracetam (ucb 34714) | |||||
2 | Active, not recruiting | Prospective Evaluation of Proteinuria and Renal Function in Non-Diabetic Patients With Progressive Renal Disease | ||||
Condition: | Hyperlipidemia | |||||
Interventions: | Drug: Rosuvastatin; Drug: Atorvastatin | |||||
3 | Active, not recruiting | Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate | ||||
Conditions: | Atrial Fibrillation; Cerebrovascular Accident | |||||
Interventions: | Drug: Dabigatran etexilate; Drug: Warfarin | |||||
4 | Completed | Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer | ||||
Conditions: | Breast Cancer; Metastases | |||||
Interventions: | Drug: Ixabepilone + Capecitabine; Drug: Capecitabine | |||||
5 | Completed | Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study | ||||
Condition: | NSCLC | |||||
Intervention: | Drug: Gefitinib | |||||
6 | Completed | A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin. | ||||
Condition: | Diabetes Mellitus, Type 2 | |||||
Interventions: | Drug: GLP-1; Drug: GLP-1; Drug: GLP-1; Drug: GLP-1; Drug: GLP-1; Drug: Placebo | |||||
7 | Recruiting | Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism | ||||
Condition: | Venous Thrombosis | |||||
Interventions: | Drug: Enoxaparin; Drug: warfarin; Drug: Placebo for apixaban; Drug: Placebo for enoxaparin; Drug: Placebo for warfarin; Drug: apixaban | |||||
8 | Completed | A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Intervention: | Drug: Certolizumab Pegol | |||||
9 | Recruiting | A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis | ||||
Condition: | Atopic Dermatitis | |||||
Interventions: | Biological: MVA-BN® (IMVAMUNE); Biological: IMVAMUNE | |||||
10 | Recruiting | PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin | ||||
Condition: | Non Hodgkin Lymphoma | |||||
Interventions: | Drug: enzastaurin; Drug: placebo | |||||
11 | Recruiting | Study of Apixaban for the Prevention of Thrombosis-Related Events in Patients With Acute Medical Illness | ||||
Conditions: | Venous Thrombosis; Pulmonary Embolism | |||||
Interventions: | Drug: Apixaban; Drug: Enoxaparin | |||||
12 | Recruiting | Phase IIIB Switching From Intravenous to Subcutaneous Study | ||||
Condition: | Arthritis, Rheumatoid | |||||
Intervention: | Drug: Abatacept | |||||
13 | Active, not recruiting | Benign Prostatic Hyperplasia Trial With AVODART And Tamsulosin Combination Treatment | ||||
Condition: | Benign Prostatic Hyperplasia | |||||
Interventions: | Drug: AVODART; Drug: Tamsulosin | |||||
14 | Completed | Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus | ||||
Condition: | Diabetes | |||||
Intervention: | Drug: Insulin sensitizer | |||||
15 | Recruiting | Study of LJP 394 in Lupus Patients With History of Renal Disease | ||||
Conditions: | Lupus Erythematosus, Systemic; Lupus Nephritis | |||||
Interventions: | Drug: abetimus sodium (LJP 394) and/or placebo solution; Drug: abetimus sodium (LJP 394); Drug: Phosphate-buffered saline | |||||
16 | Recruiting | Study Comparing 17B Estradiol/TMG CC 1mg vs. Tibolone in Postmenopausal Women | ||||
Condition: | Vasomotor Symptoms | |||||
Interventions: | Drug: Intervention 1 Arm 1: 17B Estradiol (1mg) / (0.125 mg) TMG Continuous combined; Drug: Tibolone | |||||
17 | Active, not recruiting | Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341) | ||||
Conditions: | Gastroesophageal Reflux Disease; GERD | |||||
Intervention: | Drug: Pantoprazole | |||||
18 | Completed | Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD) | ||||
Condition: | Macular Degeneration | |||||
Intervention: | Drug: Mecamylamine | |||||
19 | Active, not recruiting | A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes. | ||||
Condition: | Diabetes Mellitus, Type 2 | |||||
Interventions: | Drug: aleglitazar; Drug: Actos | |||||
20 | Active, not recruiting | A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. | ||||
Condition: | Non-Small Cell Lung Cancer | |||||
Interventions: | Drug: bevacizumab [Avastin]; Drug: Platinum-based chemotherapy | |||||
21 | Recruiting | Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia | ||||
Condition: | Bacterial Pneumonia | |||||
Interventions: | Drug: ceftaroline; Drug: ceftriaxone | |||||
22 | Active, not recruiting | Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir DF in HIV-1-Infected Treatment Naive Adults | ||||
Condition: | HIV Infections | |||||
Interventions: | Drug: Atazanavir/Ritonavir; Drug: Emtricitabine/Tenofovir DF; Drug: Nevirapine | |||||
23 | Completed | Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects | ||||
Condition: | Type 2 Diabetes Mellitus | |||||
Intervention: | Drug: rosiglitazone maleate/metformin hydrochloride | |||||
24 | Recruiting | A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator | ||||
Condition: | Type 2 Diabetes Mellitus | |||||
Interventions: | Drug: INT131 besylate; Drug: Pioglitazone HCl; Drug: Placebo | |||||
25 | Completed | A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Interventions: | Drug: tocilizumab; Drug: Methotrexate | |||||
26 | Completed | Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes | ||||
Condition: | Type 2 Diabetes Mellitus | |||||
Interventions: | Drug: Muraglitazar; Drug: Pioglitazone | |||||
27 | Completed | COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis | ||||
Condition: | Rheumatoid Arthritis | |||||
Intervention: | Drug: GW406381 | |||||
28 | Completed | Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled Corticosteroids | ||||
Condition: | Asthma | |||||
Intervention: | Drug: Dual Integrin Antagonist | |||||
29 | Recruiting | Multi-Country Observational Study to Collect the Frequency of Sexual Dysfunction With Antidepressant Treatment, Either With SSRIs or Duals at 8 Weeks and 6 Months | ||||
Condition: | Major Depressive Disorder | |||||
Interventions: | Drug: SSRIs; Drug: Dual antidepressants | |||||
30 | Recruiting | Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis | ||||
Condition: | Arthritis, Rheumatoid | |||||
Interventions: | Drug: Etanercept; Drug: Methotrexate | |||||
31 | Completed | Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose | ||||
Condition: | Diabetes Mellitus | |||||
Intervention: | Drug: Inhaled insulin | |||||
32 | Recruiting | A Study of Abatacept in Patients With Active Ulcerative Colitis | ||||
Condition: | Ulcerative Colitis | |||||
Interventions: | Drug: abatacept; Drug: placebo | |||||
33 | Completed | A Study of DPP-IV (3) in Patients With Type 2 Diabetes. | ||||
Condition: | Diabetes Mellitus, Type 2 | |||||
Interventions: | Drug: DPP-IV (3); Drug: Placebo | |||||
34 | Completed | Randomized, Double Blind, Multicenter Study of the Safety and Efficacy of Valdecoxib 40 mg Once Daily Compared With Diclofenac 75 mg Twice Daily in Acute Low Back Pain | ||||
Condition: | Low Back Pain | |||||
Interventions: | Drug: valdecoxib; Drug: diclofenac | |||||
35 | Completed | A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer | ||||
Condition: | Non Small Cell Lung Carcinoma | |||||
Interventions: | Drug: pemetrexed; Drug: gemcitabine; Drug: cisplatin | |||||
36 | Completed | Pregabalin Treatment Of Peripheral Neuropathic Pain Associated With Post-Herpetic, (HIV,Chemotherapy) Diabetic Induced | ||||
Conditions: | Neuralgia, Post-Herpetic; Diabetic Neuropathic Pain; HIV Related Peripheral Neuropathic Pain; Chemotherapy Induced Peripheral Neuropathic Pain | |||||
Intervention: | Drug: Pregabalin | |||||
37 | Active, not recruiting | Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM2) | ||||
Conditions: | HIV Infections; Acquired Immunodeficiency Syndrome | |||||
Interventions: | Drug: Vicriviroc maleate 30 mg; Drug: Placebo tablet | |||||
38 | Recruiting | Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594) | ||||
Conditions: | Neoplasms; Nausea; Vomiting | |||||
Intervention: | Drug: Palonosetron and Dexamethasone | |||||
39 | Completed | AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes | ||||
Condition: | Non-Insulin-Dependent Diabetes Mellitus | |||||
Interventions: | Drug: metformin; Drug: sulphonylurea; Drug: Avandamet | |||||
40 | Recruiting | Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis | ||||
Condition: | Relapsing-Remitting Multiple Sclerosis | |||||
Intervention: | Drug: BG00012 | |||||
41 | Completed | A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas | ||||
Condition: | Diabetes | |||||
Interventions: | Drug: Saxagliptin + Glyburide; Drug: Saxagliptin + Glyburide; Drug: Placebo + Glyburide | |||||
42 | Recruiting | A Clinical Trial Comparing Efficacy And Safety of Sunitinib And Capecitabine | ||||
Condition: | Breast Neoplasms | |||||
Interventions: | Drug: Capecitabine; Drug: Sunitinib malate | |||||
43 | Active, not recruiting | PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy | ||||
Condition: | Metastatic Colorectal Cancer | |||||
Interventions: | Drug: 5-Fluorouracil, Oxaliplatin, Leucovorin, Panitumumab; Drug: 5-Fluorouracil, Oxaliplatin, Leucovorin | |||||
44 | Recruiting | A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease. | ||||
Condition: | Post-Menopausal Osteoporosis | |||||
Interventions: | Drug: ibandronate [Bonviva/Boniva]; Drug: ibandronate [Bonviva/Boniva]; Drug: Alendronate | |||||
45 | Recruiting | LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia. | ||||
Condition: | Anemia | |||||
Intervention: | Drug: methoxy polyethylene glycol-epoetin beta [Mircera] | |||||
46 | Recruiting | A Study to Evaluate the Effectiveness and Safety of CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine | ||||
Conditions: | Tumors; Pain | |||||
Interventions: | Drug: CG5503 ER; Drug: Placebo to match CG5503; Drug: Morphine Sulphate CR; Drug: Placebo to match Morphine Sulphate CR | |||||
47 | Active, not recruiting | Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT) | ||||
Conditions: | Kidney Disease; Diabetes Mellitus; Anemia | |||||
Interventions: | Drug: darbepoetin alfa; Drug: Placebo | |||||
48 | Active, not recruiting | Enzastaurin Versus Lomustine in Glioblastoma | ||||
Condition: | Glioblastoma | |||||
Interventions: | Drug: enzastaurin; Drug: lomustine | |||||
49 | Completed | A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise | ||||
Condition: | Diabetes | |||||
Interventions: | Drug: Saxagliptin and Metformin; Drug: Saxagliptin and Metformin; Drug: Saxagliptin and Placebo; Drug: Metformin and Placebo | |||||
50 | Recruiting | RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial | ||||
Conditions: | Heart Failure; Anemia; Cardiovascular Disease; Ventricular Dysfunction; Congestive Heart Failure | |||||
Interventions: | Drug: Darbepoetin alfa; Drug: Placebo | |||||
Studies Shown (1-50) | Next (51-100) |